Dupilumab added to standard COPD triple therapy reduces the annual rate of moderate exacerbations but not severe exacerbations.
11h
KTSM 9 News on MSNString of dust storms pose risk to physical health, AC unitsEl Paso is under a Weather Authority Alert for another dust storm, which seem to be lining up one after another this February ...
Background The diagnosis of interstitial lung disease (ILD) can pose a challenge as the pulmonary function test (PFT) is only ...
We have all been born, and we will all die. But how do we want to die, and how can the final period be as good as possible?
Pooled data from the ENHANCE-1 and ENHANCE-2 studies of ensifentrine added to background treatment with ... which are standard bronchodilator therapies for COPD – showed a 40% reduction in ...
Leerink Partners 2025 Global Healthcare Conference Call March 11, 2025 8:00 AM ET. Company Participants. Ryan Crowe - SVP, IR & Strat ...
At the Jersey Shore, you’ll hear the occasional hum of an electric golf cart or strident seagull. Also inevitable, it seems, ...
Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...
Michael Schwinghamer has a passion for shipwrecks and is on a mission to capture them in their watery graves — leaning on his ...
Find out how the NMC panel acted in this case. Not yet read the case? Read the charge and background here Having found Nurse A’s fitness to practise currently impaired, the panel went on to consider ...
Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...
Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave the way for new treatment ... Zinc Deficiency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results